Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session

Deconvolution of Chromatin States in Brain Cancer using Single-Cell Epigenomic Assays

About This Webinar

Adult and pediatric glioblastomas are incurable and extremely aggressive brain cancers. Their extensive intratumoral genomic heterogeneity and their hierarchical functional organization contribute to the biological complexity of these malignancies. Single-cell omics could assist in resolving the cellular complexity of glioblastoma. However, computational bottlenecks, especially for downstream analyses of single-cell epigenomic datasets, have been obstacles in direct investigations of surgical specimens. We have created a computational tool that uses single-cell epigenomic data to differentiate between tumor and non-malignant cells in surgical samples. Analyses of pure tumor cell populations enabled by our computational tool revealed complex epigenetic behavior in individual glioblastomas, both statically and during disease progression. Our data uncover epigenomic networks that contribute to tumorigenic function, including transcription factors that dominate the chromatin landscapes of cancer stem cell populations. All together, our computational tool and single-cell epigenomic datasets could significantly improve our understanding of the complex biology of pediatric and adult glioblastoma.

Who can view: Everyone
Webinar Price: Free
Featured Presenters
Webinar hosting presenter
Assistant Professor, Cumming School of Medicine, University of Calgary
Dr Gallo completed his undergraduate degree at Simon Fraser University (Burnaby, BC) and his PhD degree at the University of British Columbia (Vancouver, BC). He undertook his postdoctoral fellowship at the Hospital for Sick Children (Toronto, ON), where he discovered epigenetic and chromatin regulatory mechanisms used by glioblastoma cells to achieve and maintain cancer stem cell states. Dr Gallo started his laboratory at the University of Calgary in December 2015. His research interests focus on decoding the relationships between epigenomic features and cancer stem cell phenotypes in adult and pediatric brain cancers by integrating genomic and functional assays with patient-derived preclinical models.
Hosted By
 Illumina  webinar platform hosts  Deconvolution of Chromatin States in Brain Cancer using Single-Cell Epigenomic Assays
Illumina 's webinars
Attended (256)
Recommended